ZYNRELEF (BUPivacaine 60 mg / meloxicam 1.8 mg) in 2.3 mL Extended Release Solution
RxNorm 2560311
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2560311 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ZYNRELEF (BUPivacaine 60 mg / meloxicam 1.8 mg) in 2.3 mL Extended Release Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
2.3 mL bupivacaine 29.3 mg/ML / meloxicam 0.88 mg/ML Injection [Zynrelef]
(Atom ID: 12650835)
TMSY
Tall Man Lettering Synonym (TMSY):
2.3 mL BUPivacaine 29.3 mg/ML / meloxicam 0.88 mg/ML Injection [Zynrelef]
(Atom ID: 12815464)
PSN
Prescribable Name (PSN):
ZYNRELEF (BUPivacaine 60 mg / meloxicam 1.8 mg) in 2.3 mL Extended Release Solution
(Atom ID: 12650845)
SY
Synonym (SY):
Zynrelef (bupivacaine 60 mg / meloxicam 1.8 mg) per 2.3 mL Extended Release Solution
(Atom ID: 12650846)
TMSY